膜型ループス腎炎に対するシクロスポリンを含む4薬併用療法
Saved in:
Published in | 日本腎臓学会誌 Vol. 45; no. 7; pp. 689 - 694 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | Japanese |
Published |
社団法人 日本腎臓学会
25.10.2003
|
Online Access | Get full text |
ISSN | 0385-2385 1884-0728 |
DOI | 10.14842/jpnjnephrol1959.45.689 |
Cover
Author | 松本, 博 中尾, 俊之 岡田, 知也 長岡, 由女 外丸, 良 岩澤, 秀明 和田, 憲和 |
---|---|
Author_xml | – sequence: 1 fullname: 岡田, 知也 organization: 東京医科大学腎臓科 – sequence: 1 fullname: 岩澤, 秀明 organization: 東京医科大学腎臓科 – sequence: 1 fullname: 長岡, 由女 organization: 東京医科大学腎臓科 – sequence: 1 fullname: 外丸, 良 organization: 東京医科大学腎臓科 – sequence: 1 fullname: 中尾, 俊之 organization: 東京医科大学腎臓科 – sequence: 1 fullname: 松本, 博 organization: 東京医科大学腎臓科 – sequence: 1 fullname: 和田, 憲和 organization: 東京医科大学腎臓科 |
BookMark | eNpdkM1Kw0AUhQdRsNY-g0-QOpPMTGaWUvzDgiC6DtN0YhtqWpJu3NkJuikUEX8oqGuxShdFRFBf5lrbxzBQceHmu9xzD5fDWULzUTPSCK0QXCRUUHs1bEVhpFu1uNkgkskiZUUu5BzKESGohV1bzKMcdgSz7AyLqJAk9QomwsUOc2kO7U3Pbsf3XUgHkL5DegPmbXram5gedAbj4Sd0-mC6YF7BDCF9zq6Q3kH6COkIzMX4fADmhE6vn74-XiaXD5O--R5dLaOFQDUSXfideXSwsb5f2rLKu5vbpbWyFRImlGUHGPOgattKVmwifcY0oVk0zTjmPsZOprJsd7kIfM60JMwlDiU-rTpY8sDJo53Z3zBpq0PtteL6kYqPPRW3635De_-q8Sjz3Bmyhv5cfk3FXqicH77BgCo |
ContentType | Journal Article |
Copyright | 社団法人日本腎臓学会 |
Copyright_xml | – notice: 社団法人日本腎臓学会 |
DOI | 10.14842/jpnjnephrol1959.45.689 |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 1884-0728 |
EndPage | 694 |
ExternalDocumentID | article_jpnjnephrol1959_45_7_45_7_689_article_char_ja |
GroupedDBID | ALMA_UNASSIGNED_HOLDINGS JSF KQ8 OK1 RJT |
ID | FETCH-LOGICAL-j158a-2f006fd22a9b219c55e14b01e5606c003b215b01768fc65e91571341c4d3096f3 |
ISSN | 0385-2385 |
IngestDate | Wed Sep 03 05:55:43 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 7 |
Language | Japanese |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-j158a-2f006fd22a9b219c55e14b01e5606c003b215b01768fc65e91571341c4d3096f3 |
OpenAccessLink | https://www.jstage.jst.go.jp/article/jpnjnephrol1959/45/7/45_7_689/_article/-char/ja |
PageCount | 6 |
ParticipantIDs | jstage_primary_article_jpnjnephrol1959_45_7_45_7_689_article_char_ja |
PublicationCentury | 2000 |
PublicationDate | 2003/10/25 |
PublicationDateYYYYMMDD | 2003-10-25 |
PublicationDate_xml | – month: 10 year: 2003 text: 2003/10/25 day: 25 |
PublicationDecade | 2000 |
PublicationTitle | 日本腎臓学会誌 |
PublicationTitleAlternate | 日腎会誌 |
PublicationYear | 2003 |
Publisher | 社団法人 日本腎臓学会 |
Publisher_xml | – name: 社団法人 日本腎臓学会 |
References | 16. Shapia Y, Mor F, Freidler A, Wysenbeek AJ, Weinberger A. Antiproteinuric effect of captopril in a patient with lupus nephritis and intractable nephrotic syndrome. Ann Rheum Dis 1990 ; 49 : 725-727. 21. Chishti AS, Sorof JM, Brewer ED, Kale A. Long-term treatment of focal segmental glomerulosclerosis in children with cyclosporine given as a single daily dose. Am J Kidney Dis 2001 ; 38 : 754-760. 14. Radhakrishnan J, Kunis CL, D'Agati V, Appcl GB. Cyclosporine treatment of lupus membranous nephropathy. Clin Nephrol 1994 ; 42 :147 154. 11. Pasquali S, Banfi G, Zucchelli A, Moroni G, Ponticelli C, Zucchelli P. Lupus membranous nephropathy : long-term outcome. Clin Nephrol 1993 ; 39 :175-182. 20. Meyrier A, Noel LH, Ariche P, Collard P, Collaborative Group of the Societe de Nephrologie. Long-term renal tolerance of cyclosporin A treatment in adult nephrosis. Kidney Int 1994 ; 45 :1446-1456. 1. Donadio JV, Burgess JH, Holly KE. Membranous lupus nephropathy : a clinicopathologic study. Medicine 1977 ; 56 : 527-536. 2. Friend PS, Kim Y, Michael AF, Donadio JV. Pathogenesis of membranous lupus nephropathy in systemic lupus eryth ematosus : possible role of nonprecipitating DNA antibody. Br Med J 1977 ; 1 : 25. 18. Ishikawa A, Fujita K, Suzuki K. The influence of temocapril, an angiotensin converting enzyme inhibitor, on the cyclosporine-induced nephrotoxity. J Urol 1997 ; 157: 739-742. 22. Einecke G, Mai I, Diekmann F, Fritsche L, Neumayer HH, Budde K. Cyslosporine absorption profiling and therapeutic drug monitoring using C2 blood levels in stable renal allograft recipients. Transplant Proceed 2002 ; 34 : 1738-1739. 15. Tokuda M, Kurata N, Mizoguchi A, Inoh M, Seto K. Kinashi M, Takahara J. Effect of low-dose cyclosporin A on systemic lupus erythmatosus disease activity. Arthritis Rheum 1994 ; 37 : 551-558. 19. Feutren G, Mihatsch MJ. For the International Kidney Biopsy Registry of Cyclosporine in Autoimmune Disease Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. N Engl J Med 1992 ;326 :1654-1660. 12. Chan TM, Li FK, Hao WK, Chan KW, Lui SL, Tang S. Treatment of membranous lupus nephritis with nephrotic syndrome by sequential immunosuppression. Lupus 1999 ; 8 : 545-551. 7. Baldwin DS, Gluck MC, Lowenstein J, Gallo GR. Lupus nephritis. Clinical course as related to morphologic forms and their transitions. Am J Med 1977 ; 62 : 12-30. 5. Boumpas DT, Austin HA III, Vaughan EM, Klippel JH, Steinberg AD, Yarboro CH, Balow JF. Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet 1992 ; 340 : 741-745. 9. 槇野博史,山崎康司,林 義和,原本俊則,四方賢一,熊谷功,谷合一陽,高橋香代,太田善介.ループス腎炎に対するメチルプレドニゾロンパルス療法の組織型よりみた効果.日腎会誌1990;32:791-799. 13. Cattran DC, Greenwood C, Ritchie S, Bernstein K, Churchill DN, Clark WF, Marrin PA, Lavoie S. A controlled trial of cyclosporine in patients with progressive membranous nephropathy. Canadian Glomerulonephritis Study Group. Kidney lnt 1995 ; 47 : 1130-1135. 8. 市川陽一,斉藤栄造,阿部好文,鈴木康夫.ステロイド剤のパルス療法.最新医学1980;35:1379-1386. 17. Nakano M, Ueno M, Hasegawa H, Watanabe T, Kuroda T, Ito S, Arakawa M. Renal haemodynamics in patients with lupus nephritis. Ann Rheum Dis 1998 ; 57 : 226-230. 4. Mercadal L, du Montcel ST, Nochy D, Queffeulou G, Piette JC, Isnard-Bagnis C, Martinez F, the Groupe d'Etudes Nephrologiques en lie de France. Factors affecting outcome and prognosis in membranous lupus nephropathy. Nephrol Dial Transplant 2002 ; 17 :1771 -1778. 3. Kolasinski SL, Chung JB, Albert DA. What do we know about lupus membranous nephropathy? An analytic review. Arthritis Rheum 2002 ; 47 : 450-455. 6. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on PrognosisStudies in SLE. Arthritis Rheum 1992 ; 35 : 630-640. 10. Moroni G, Maccario M, Banfi G, Quaglini S, Ponticelli C, FRCP. Treatment of membranous lupus nephritis. Am J Kidney Dis 1998 ; 31: 681-686. |
References_xml | – reference: 14. Radhakrishnan J, Kunis CL, D'Agati V, Appcl GB. Cyclosporine treatment of lupus membranous nephropathy. Clin Nephrol 1994 ; 42 :147 154. – reference: 21. Chishti AS, Sorof JM, Brewer ED, Kale A. Long-term treatment of focal segmental glomerulosclerosis in children with cyclosporine given as a single daily dose. Am J Kidney Dis 2001 ; 38 : 754-760. – reference: 10. Moroni G, Maccario M, Banfi G, Quaglini S, Ponticelli C, FRCP. Treatment of membranous lupus nephritis. Am J Kidney Dis 1998 ; 31: 681-686. – reference: 12. Chan TM, Li FK, Hao WK, Chan KW, Lui SL, Tang S. Treatment of membranous lupus nephritis with nephrotic syndrome by sequential immunosuppression. Lupus 1999 ; 8 : 545-551. – reference: 2. Friend PS, Kim Y, Michael AF, Donadio JV. Pathogenesis of membranous lupus nephropathy in systemic lupus eryth ematosus : possible role of nonprecipitating DNA antibody. Br Med J 1977 ; 1 : 25. – reference: 3. Kolasinski SL, Chung JB, Albert DA. What do we know about lupus membranous nephropathy? An analytic review. Arthritis Rheum 2002 ; 47 : 450-455. – reference: 7. Baldwin DS, Gluck MC, Lowenstein J, Gallo GR. Lupus nephritis. Clinical course as related to morphologic forms and their transitions. Am J Med 1977 ; 62 : 12-30. – reference: 20. Meyrier A, Noel LH, Ariche P, Collard P, Collaborative Group of the Societe de Nephrologie. Long-term renal tolerance of cyclosporin A treatment in adult nephrosis. Kidney Int 1994 ; 45 :1446-1456. – reference: 11. Pasquali S, Banfi G, Zucchelli A, Moroni G, Ponticelli C, Zucchelli P. Lupus membranous nephropathy : long-term outcome. Clin Nephrol 1993 ; 39 :175-182. – reference: 19. Feutren G, Mihatsch MJ. For the International Kidney Biopsy Registry of Cyclosporine in Autoimmune Disease Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. N Engl J Med 1992 ;326 :1654-1660. – reference: 6. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on PrognosisStudies in SLE. Arthritis Rheum 1992 ; 35 : 630-640. – reference: 9. 槇野博史,山崎康司,林 義和,原本俊則,四方賢一,熊谷功,谷合一陽,高橋香代,太田善介.ループス腎炎に対するメチルプレドニゾロンパルス療法の組織型よりみた効果.日腎会誌1990;32:791-799. – reference: 18. Ishikawa A, Fujita K, Suzuki K. The influence of temocapril, an angiotensin converting enzyme inhibitor, on the cyclosporine-induced nephrotoxity. J Urol 1997 ; 157: 739-742. – reference: 1. Donadio JV, Burgess JH, Holly KE. Membranous lupus nephropathy : a clinicopathologic study. Medicine 1977 ; 56 : 527-536. – reference: 13. Cattran DC, Greenwood C, Ritchie S, Bernstein K, Churchill DN, Clark WF, Marrin PA, Lavoie S. A controlled trial of cyclosporine in patients with progressive membranous nephropathy. Canadian Glomerulonephritis Study Group. Kidney lnt 1995 ; 47 : 1130-1135. – reference: 17. Nakano M, Ueno M, Hasegawa H, Watanabe T, Kuroda T, Ito S, Arakawa M. Renal haemodynamics in patients with lupus nephritis. Ann Rheum Dis 1998 ; 57 : 226-230. – reference: 4. Mercadal L, du Montcel ST, Nochy D, Queffeulou G, Piette JC, Isnard-Bagnis C, Martinez F, the Groupe d'Etudes Nephrologiques en lie de France. Factors affecting outcome and prognosis in membranous lupus nephropathy. Nephrol Dial Transplant 2002 ; 17 :1771 -1778. – reference: 5. Boumpas DT, Austin HA III, Vaughan EM, Klippel JH, Steinberg AD, Yarboro CH, Balow JF. Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet 1992 ; 340 : 741-745. – reference: 8. 市川陽一,斉藤栄造,阿部好文,鈴木康夫.ステロイド剤のパルス療法.最新医学1980;35:1379-1386. – reference: 16. Shapia Y, Mor F, Freidler A, Wysenbeek AJ, Weinberger A. Antiproteinuric effect of captopril in a patient with lupus nephritis and intractable nephrotic syndrome. Ann Rheum Dis 1990 ; 49 : 725-727. – reference: 22. Einecke G, Mai I, Diekmann F, Fritsche L, Neumayer HH, Budde K. Cyslosporine absorption profiling and therapeutic drug monitoring using C2 blood levels in stable renal allograft recipients. Transplant Proceed 2002 ; 34 : 1738-1739. – reference: 15. Tokuda M, Kurata N, Mizoguchi A, Inoh M, Seto K. Kinashi M, Takahara J. Effect of low-dose cyclosporin A on systemic lupus erythmatosus disease activity. Arthritis Rheum 1994 ; 37 : 551-558. |
SSID | ssib018703574 ssib004261733 ssib058493074 ssib000833381 ssib002004354 ssib005879731 ssib039893136 ssib008531636 ssib038076193 ssj0000696431 ssib000940323 ssib002822005 ssib038586121 ssib047305546 |
Score | 1.6218436 |
SourceID | jstage |
SourceType | Publisher |
StartPage | 689 |
Title | 膜型ループス腎炎に対するシクロスポリンを含む4薬併用療法 |
URI | https://www.jstage.jst.go.jp/article/jpnjnephrol1959/45/7/45_7_689/_article/-char/ja |
Volume | 45 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | 日本腎臓学会誌, 2003/10/25, Vol.45(7), pp.689-694 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrR1Na9RANJR68SJKFb_pwTlJ6iYzk5k5JrtZqqIHaaG3ZZNNDotsRdqLJ5tFL4Ui4gcF9SxW6aGICOqfGWv7M3xvJsmmtQctwhLm4703b97L7Lw3mXnjONcokxh1qu8mPM1cphLh9nMhQCEpl2rgy1aKC_p37gbzi-zWEl-amp5p7FpaXUnm0kdHnis5jlahDPSKp2T_QbM1USiANOgXnqBheP6VjkksiQyIapOYExUTGZGYEklJWCWidplQwiR8EimDxYmMSSywBBNQ5RksTsIuiaoSpUqskjKgV3QArGyr06Bs2-pUVWHFBi1hlG9YbVUc4k4LhgypgITAKyNRh0QcOVOMhNIkFMLFAVKxV2VW1jQWQsdCbhJtQ6HuGyQAl5oudUgYGOJtokKsAs5kvT6MIBH0yCubjVr44plM1xBn2DfVPQyvDFMxCVkFHwrcOYLMQOvxBB6wuRFd1VBFHyh7hkOooE36QFNZliX-DDzQVCD3Aws1ZsufPdRthpbhghkNgpwjEtJacoZaCL_rx5NbY86gkrtghdlmMzunScnclijP4JeTno3hWQ5u0ZjBAnujU2kMBfYG6j_mWSYZBu4dPhgNRxn86yzfxyBFc4zP1fgHgpiXQ6R3CKHHeE_YB-D1Kig8cNgbgtdzwhfCbr64ebvpNFDaPD2uWIs2jXj8ut0MEgg28KE7GTzRcHK4FHh_W50HAxaclNpI92BGo3ziJOENDYE3mdXwyzqG4avzClwAb4LPBAbVmyy6gMWvaBWBytqLGBPPXO1Zaa_ciIpSvnG0jMFgHoL7WG09NdbwwmnnVOnGzoZWlGecqWF_xrm3__TN7rt1Pd7S4296_FoXX_efbOwVG3pta3f7h17b1MW6Lr7oYluPP0GtHr_V4w96vKOL57vPtnTxmO2_-vjz--e9F-_3NotfOy_POovdeKE975Z3trhDj8u-6-fQn3zg-32VgDGUcp55DISYgWcVpDAqoJRDXgQyTwOeKY_jaXYvZQPaUkFOzznTo-VRdt6ZDVju9fMkSfMMLI3Ulwk4s2mSJDQF4nRwwelYEfQe2MA8vWO9ZRf_D5lLzsnJoL_sTK88XM2ugL-yklw1r-9vX0z_eA |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E8%86%9C%E5%9E%8B%E3%83%AB%E3%83%BC%E3%83%97%E3%82%B9%E8%85%8E%E7%82%8E%E3%81%AB%E5%AF%BE%E3%81%99%E3%82%8B%E3%82%B7%E3%82%AF%E3%83%AD%E3%82%B9%E3%83%9D%E3%83%AA%E3%83%B3%E3%82%92%E5%90%AB%E3%82%804%E8%96%AC%E4%BD%B5%E7%94%A8%E7%99%82%E6%B3%95&rft.jtitle=%E6%97%A5%E6%9C%AC%E8%85%8E%E8%87%93%E5%AD%A6%E4%BC%9A%E8%AA%8C&rft.au=%E5%B2%A1%E7%94%B0%2C+%E7%9F%A5%E4%B9%9F&rft.au=%E5%B2%A9%E6%BE%A4%2C+%E7%A7%80%E6%98%8E&rft.au=%E9%95%B7%E5%B2%A1%2C+%E7%94%B1%E5%A5%B3&rft.au=%E5%A4%96%E4%B8%B8%2C+%E8%89%AF&rft.date=2003-10-25&rft.pub=%E7%A4%BE%E5%9B%A3%E6%B3%95%E4%BA%BA+%E6%97%A5%E6%9C%AC%E8%85%8E%E8%87%93%E5%AD%A6%E4%BC%9A&rft.issn=0385-2385&rft.eissn=1884-0728&rft.volume=45&rft.issue=7&rft.spage=689&rft.epage=694&rft_id=info:doi/10.14842%2Fjpnjnephrol1959.45.689&rft.externalDocID=article_jpnjnephrol1959_45_7_45_7_689_article_char_ja |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0385-2385&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0385-2385&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0385-2385&client=summon |